abscisic acid
PulseAugur coverage of abscisic acid — every cluster mentioning abscisic acid across labs, papers, and developer communities, ranked by signal.
- 2026-07-01 funding Eli Lilly led a $100 million stock offering in Absci with a $40 million investment. source
1 day(s) with sentiment data
-
AI Enhances Antibody Design, But Lab Work Remains Crucial
Artificial intelligence has shown promise in enhancing the design of therapeutic antibodies, according to a recent study. While AI can improve existing drug candidates, the research emphasizes that traditional laborator…
-
Pangram AI detection tool sparks debate over accuracy and ethics · 4 sources tracked
Pangram, an AI startup, has gained significant attention for its AI detection technology, which claims to identify the percentage of AI involvement in written text. The company has raised $13 million and recently launch…
-
Baldness drugs emerge as Wall Street's next major investment opportunity
Wall Street is increasingly focusing on the development of new baldness treatments, viewing them as a significant investment opportunity akin to the recent boom in obesity drugs. Companies like Veradermics, Absci Corp.,…
-
Eli Lilly invests $40M in AI drug firm Absci for baldness treatment
Eli Lilly has invested $40 million in Absci, a generative AI drug discovery company, as part of a larger $100 million stock offering. Absci utilized AI to design ABS-201, an injectable antibody targeting a hormone recep…
-
Mastodon user jokes about hair loss treatment trial and stock surge
A user on Mastodon shared a link to a Morningstar article about Absci's stock performance following a trial for a hair loss treatment. The user humorously suggested they would take the treatment with no side effects, no…
-
AI talent shortage spurs biotech hiring, research labs
Biotechnology companies are facing a significant challenge in recruiting artificial intelligence talent due to a shortage of individuals skilled in both deep learning and life sciences. Absci, an AI-powered drug discove…